04/12/2024 4:59 PM | Srinivasan Venkatesh (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 4:10 PM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 3:58 PM | Sutro Biopharma (Filer)
| Form 424B5 | |
04/02/2024 5:04 AM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 3:30 PM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/22/2024 3:28 PM | NEWELL WILLIAM J (Reporting) Sutro Biopharma (Issuer)
| Form 4/A | |
03/07/2024 6:12 PM | FITZPATRICK LINDA A (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/07/2024 3:26 PM | Chung Jane (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 3:28 PM | Gerber Hans-Peter (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 3:31 PM | NEWELL WILLIAM J (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 3:32 PM | Srinivasan Venkatesh (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:18 PM | ALBINI EDWARD C (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:21 PM | Chung Jane (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:40 PM | NEWELL WILLIAM J (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:29 PM | ALBINI EDWARD C (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 3:15 PM | Borgman Anne Elizabeth (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 3:33 PM | Sutro Biopharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/13/2024 11:16 AM | Sutro Biopharma (Subject) SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/12/2024 5:06 AM | Rubric Capital Management LP (Filed by) Sutro Biopharma (Subject)
| Form SC 13G/A | |
02/09/2024 3:27 PM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/07/2024 6:56 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Sutro Biopharma (Subject)
| Form SC 13G/A | |
01/31/2024 3:23 PM | Sutro Biopharma (Issuer) Vasquez Nicki (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:25 PM | FITZPATRICK LINDA A (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:28 PM | ALBINI EDWARD C (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:29 PM | NEWELL WILLIAM J (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:54 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by) Sutro Biopharma (Subject)
| Form SC 13G | |
01/08/2024 6:31 AM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/04/2023 3:19 PM | Chung Jane (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 11:15 PM | Sutro Biopharma (Filer)
| Form EFFECT | |
11/21/2023 3:05 PM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 4:18 PM | Sutro Biopharma (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
11/13/2023 3:30 PM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 3:32 PM | Sutro Biopharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/10/2023 3:52 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Sutro Biopharma (Subject)
| Form SC 13G | |
10/04/2023 3:31 PM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/19/2023 3:19 PM | Gerber Hans-Peter (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 3:15 PM | Gerber Hans-Peter (Reporting) Sutro Biopharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/29/2023 3:40 PM | Shtylla Brunilda (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2023 3:18 PM | Shtylla Brunilda (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 3:46 PM | Shtylla Brunilda (Reporting) Sutro Biopharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023 5:40 PM | Sutro Biopharma (Issuer) Vasquez Nicki (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
$21,000 in profits in six weeks? (Ad) On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit.
Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges. Click here for details. |
06/29/2023 5:28 PM | Petree Daniel H (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 7:01 AM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2023 3:31 PM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2023 5:51 PM | Hunter Heidi (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 5:30 PM | Dybbs Michael (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 5:32 PM | Freund John Gordon (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 5:37 PM | Lobacki Joseph M (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 5:38 PM | MATSUI CONNIE (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 5:38 PM | PANEK JAMES P (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 5:39 PM | Petree Daniel H (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 5:40 PM | Sutro Biopharma (Issuer) Wigginton Jon Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 7:01 AM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2023 7:05 AM | Sutro Biopharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |